首页> 外文期刊>Virus Research: An International Journal of Molecular and Cellular Virology >Construction of green fluorescent protein-tagged recombinant iridovirus to assess viral replication.
【24h】

Construction of green fluorescent protein-tagged recombinant iridovirus to assess viral replication.

机译:构建绿色荧光蛋白标签的重组虹膜病毒,以评估病毒复制。

获取原文
获取原文并翻译 | 示例
           

摘要

Green fluorescent protein-tagged recombinant virus has been successfully applied to observing the infective dynamics and evaluating viral replication. Here, we identified soft-shelled turtle iridovirus (STIV) ORF55 as an envelope protein (VP55), and developed a recombinant STIV expressing an enhanced green fluorescent protein (EGFP) fused to VP55 (EGFP-STIV). Recombinant EGFP-STIV shared similar single-step growth curves and ultrastructural morphology with wild type STIV (wt-STIV). The green fluorescence distribution during EGFP-STIV infection was consistent with the intracellular distribution of VP55 which was mostly co-localized with virus assembly sites. Furthermore, EGFP-STIV could be used to evaluate viral replication conveniently under drug treatment, and the result showed that STIV replication was significantly inhibited after the addition of antioxidant pyrrolidine dithiocarbamate (PDTC). Thus, the EGFP-tagged recombinant iridovirus will not only be useful for further investigations on the viral replicative dynamics, but also provide an alternative simple strategy to screen for antiviral substances.
机译:带有绿色荧光蛋白标签的重组病毒已成功应用于观察感染动力学和评估病毒复制。在这里,我们确定了甲壳病毒虹膜病毒(STIV)ORF55作为包膜蛋白(VP55),并开发了表达融合了VP55的增强型绿色荧光蛋白(EGFP)的重组STIV(EGFP-STIV)。重组EGFP-STIV与野生型STIV(wt-STIV)具有相似的单步生长曲线和超微结构。 EGFP-STIV感染期间的绿色荧光分布与VP55的细胞内分布一致,VP55主要与病毒装配位点共定位。此外,EGFP-STIV可以方便地在药物治疗下评估病毒复制,结果表明,加入抗氧化剂吡咯烷二硫代氨基甲酸酯(PDTC)后,STIV复制受到明显抑制。因此,标记有EGFP的重组虹膜病毒不仅可用于进一步研究病毒复制动力学,而且还提供了筛选抗病毒物质的替代性简单策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号